Document Detail


Topiramate and temporal lobe epilepsy: an open-label study.
MedLine Citation:
PMID:  22576069     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To evaluate the efficacy and tolerability of topiramate (TPM) as monotherapy for patients with temporal lobe epileptic seizures based on an observational study.
METHODS: We evaluated 41 patients (20 female, mean age 54+18 years) with temporal lobe epilepsy (TLE) referred to the Epilepsy Unit, University of Catanzaro, Italy. Patients received TPM as monotherapy directly or after having taken other antiepileptic drugs. Seizure frequency changes and adverse events were recorded. Follow-up was conducted for a period of at least two years after treatment.
RESULTS: Patients received TPM, 50-600 mg/day, de novo (n=29) or initially as add-on therapy before the switch (n=12). In total, 28 of 41 patients achieved seizure freedom, whereas 10 showed a ≥ 50% reduction of seizure frequency. Two patients did not respond well and one patient discontinued TPM due to adverse effects.
CONCLUSIONS: Our results confirm that TPM as either monotherapy or add-on therapy at doses of 50-600 mg/day effectively reduces seizure frequency in TLE. TPM is particular effective and very well tolerated in patients with mild TLE.
Authors:
Angelo Labate; Antonio Siniscalchi; Laura Mumoli; Umberto Aguglia; Aldo Quattrone; Antonio Gambardella
Related Documents :
9256539 - Prevention of severe mucosecretory ear disease and its complications in patients with c...
15352869 - A cephalometric evaluation of lower lip in patients with unilateral cleft lip and palate.
269949 - Let /s/ be your guide.
135669 - Variations in size of the bony lumbar canal in patients with prolapse of lumbar interve...
20203279 - Keratocystic odontogenic tumour in a hong kong community: the clinical and radiological...
7953999 - Experience with furlow palatoplasty.
19362039 - Premalignant nature of oral lichen planus. a retrospective study of 550 oral lichen pla...
6871879 - Monocyte-mediated antibody-dependent cell-mediated cytotoxicity and spontaneous cytotox...
9431329 - Predicting in-hospital deaths from coronary artery bypass graft surgery. do different s...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Epileptic disorders : international epilepsy journal with videotape     Volume:  14     ISSN:  1294-9361     ISO Abbreviation:  Epileptic Disord     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-06-25     Completed Date:  2012-10-10     Revised Date:  2013-08-21    
Medline Journal Info:
Nlm Unique ID:  100891853     Medline TA:  Epileptic Disord     Country:  France    
Other Details:
Languages:  eng     Pagination:  163-6     Citation Subset:  IM    
Affiliation:
Institute of Neurology, University Magna Græcia, Catanzaro, Italy. labate@unicz.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age of Onset
Aged
Anticonvulsants / therapeutic use*
Drug Resistance
Electroencephalography
Epilepsy, Temporal Lobe / drug therapy*
Female
Fever / complications
Follow-Up Studies
Fructose / analogs & derivatives*,  therapeutic use
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Seizures / etiology
Chemical
Reg. No./Substance:
0/Anticonvulsants; 0H73WJJ391/topiramate; 30237-26-4/Fructose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk Stratification in Oral Cavity Squamous Cell Carcinoma by Preoperative CRP and SCC Antigen Level...
Next Document:  Motherhood in Women with Serious Mental Illness.